Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,635 | -33,018 | N/A | N/A | N/A |
| Depreciation Amortization | 404 | 221 | N/A | N/A | N/A |
| Accounts receivable | -104 | -158 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -386 | 3,378 | N/A | N/A | N/A |
| Other Working Capital | 41,415 | 11,641 | N/A | N/A | N/A |
| Other Operating Activity | 27,729 | -315 | 0 | 0 | 0 |
| Operating Cash Flow | $15,423 | $-18,251 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -373 | -1,783 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -40 | 0 | 0 | 0 |
| Investing Cash Flow | $-373 | $-1,823 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,950 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 6 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 26,938 | 0 | 0 | 0 |
| Financing Cash Flow | $9,956 | $26,938 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 14,548 | 7,684 | N/A | N/A | N/A |
| End Cash Position | 39,554 | 14,548 | N/A | N/A | N/A |
| Net Cash Flow | $25,006 | $6,864 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,423 | -18,251 | N/A | N/A | N/A |
| Capital Expenditure | -373 | -1,783 | N/A | N/A | N/A |
| Free Cash Flow | 15,050 | -20,034 | 0 | 0 | 0 |